3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like 4C Medical Tech Exceeds $8 Million Convertible Note Financing Round Led By July 18, 2017 Why an Acquisition of This CAR-T Biotech Makes Sense March 9, 2017 What You Need to Know About Cirius Therapeutics January 8, 2018
